48 related articles for article (PubMed ID: 16340132)
1. Inhibition of NFAT increases osteoblast differentiation by increasing Fra-2 expression.
Zayzafoon M
J Musculoskelet Neuronal Interact; 2005; 5(4):347. PubMed ID: 16340132
[No Abstract] [Full Text] [Related]
2. NFAT and Osterix cooperatively regulate bone formation.
Koga T; Matsui Y; Asagiri M; Kodama T; de Crombrugghe B; Nakashima K; Takayanagi H
Nat Med; 2005 Aug; 11(8):880-5. PubMed ID: 16041384
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation.
Yeo H; Beck LH; McDonald JM; Zayzafoon M
Bone; 2007 Jun; 40(6):1502-16. PubMed ID: 17392048
[TBL] [Abstract][Full Text] [Related]
4. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.
Gordon JA; Tye CE; Sampaio AV; Underhill TM; Hunter GK; Goldberg HA
Bone; 2007 Sep; 41(3):462-73. PubMed ID: 17572166
[TBL] [Abstract][Full Text] [Related]
5. NFATc1: a novel anabolic therapeutic target for osteoporosis.
Yeo H; McDonald JM; Zayzafoon M
Ann N Y Acad Sci; 2006 Apr; 1068():564-7. PubMed ID: 16831953
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
[TBL] [Abstract][Full Text] [Related]
7. Application of small interfering RNA for inhibition of lipopolysaccharide-induced osteoclast formation and cytokine stimulation.
Fahid FS; Jiang J; Zhu Q; Zhang C; Filbert E; Safavi KE; Spångberg LS
J Endod; 2008 May; 34(5):563-9. PubMed ID: 18436035
[TBL] [Abstract][Full Text] [Related]
8. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
[TBL] [Abstract][Full Text] [Related]
10. Baicalein stimulates osteoblast differentiation via coordinating activation of MAP kinases and transcription factors.
Kim JM; Lee SU; Kim YS; Min YK; Kim SH
J Cell Biochem; 2008 Aug; 104(5):1906-17. PubMed ID: 18384125
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
12. PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts.
Ali MM; Yoshizawa T; Ishibashi O; Matsuda A; Ikegame M; Shimomura J; Mera H; Nakashima K; Kawashima H
J Cell Sci; 2007 Aug; 120(Pt 15):2565-73. PubMed ID: 17623776
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB mediates the transcription of mouse calsarcin-1 gene, but not calsarcin-2, in C2C12 cells.
Wang H; Yang S; Yang E; Zhu Z; Mu Y; Feng S; Li K
BMC Mol Biol; 2007 Mar; 8():19. PubMed ID: 17341303
[TBL] [Abstract][Full Text] [Related]
14. Compressive force stimulates the expression of osteogenesis-related transcription factors in ROS 17/2.8 cells.
Yanagisawa M; Suzuki N; Mitsui N; Koyama Y; Otsuka K; Shimizu N
Arch Oral Biol; 2008 Mar; 53(3):214-9. PubMed ID: 18054892
[TBL] [Abstract][Full Text] [Related]
15. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
Son E; Do H; Joo HM; Pyo S
Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.
Nakayama T; Hieshima K; Arao T; Jin Z; Nagakubo D; Shirakawa AK; Yamada Y; Fujii M; Oiso N; Kawada A; Nishio K; Yoshie O
Oncogene; 2008 May; 27(23):3221-32. PubMed ID: 18071306
[TBL] [Abstract][Full Text] [Related]
17. [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
Zhang YJ; Dong LF; Wang YL
Yao Xue Xue Bao; 2006 Oct; 41(10):913-6. PubMed ID: 17184105
[No Abstract] [Full Text] [Related]
18. Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells.
Ouyang W; Hu Y; Li J; Ding M; Lu Y; Zhang D; Yan Y; Song L; Qu Q; Desai D; Amin S; Huang C
Carcinogenesis; 2007 Oct; 28(10):2218-26. PubMed ID: 17522069
[TBL] [Abstract][Full Text] [Related]
19. The calcineurin-NFAT pathway and bone: intriguing new findings.
Stern PH
Mol Interv; 2006 Aug; 6(4):193-6. PubMed ID: 16960140
[TBL] [Abstract][Full Text] [Related]
20. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
